Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
life sciences
national blog main
new york blog main
3
×
amgen
boston blog main
boston top stories
clinical trials
fda
national top stories
new york top stories
novartis
san diego blog main
san diego top stories
startups
the medicines company
abbvie
achaogen
adams street partners
adverum biotechnologies
albert bourla
alirocumab
alnylam pharmaceuticals
alzheimer's disease
amicus therapeutics
antibiotics
arvinas
batten disease
bayer
beta lactamase inhibitor
biogen
biomedical advanced research and development authority (barda)
boulder/denver blog main
boulder/denver top stories
breast cancer
brian stuglik
cancer diagnostics
cancer immunotherapy
casimir trials
What
company
3
×
drug
3
×
medicines
acquire
acquisitions
agreed
albert
bacteria
biggest
billion
bio
biopharma
bourla
brings
business
cash
ceo
cholesterol
compound
crispr
deal
disease
exited
fda
fighting
future
imports
infections
infectious
launches
maker
maps
measured
medco
melinta
new
novartis
patients
pfizer
pfizer’s
Language
unknown
unset
Current search:
company
×
drug
×
" new york blog main "
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
